SK Chemicals to conduct Phase 1 trial of flu vaccine

Published: 2012-09-27 06:57:00

Updated: 2012-09-27 06:57:00

SK Chemicals said Tuesday that it will carry out Phase 1 clinical trial on its cell-culture based influenza vaccine in collaboration with the government.

The Korea Food and Drug Administration has already given the local pharmaceutical maker the green light to conduct such clinical trial, the ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK